European Expansion of Cannvas Continues With Strong Focus on Intelligent Cannabis Education for Emerging $8B Market
Cannvas Selected to Join The International Cannabis Alliance as Exclusive Provider of Cannabis Education
Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment